Van de GraffKLoonenAHovensJEvan HalenLvan DijkeATulenJ.Pilot study of the effects of rivastigmine in schizophrenia. J Eur Coll Neuropsychopharmacol2003;13(Suppl 4):S315.
2.
AndreasenN.The Scale for Assessment of Negative Symptoms (SANS). Iowa City (IA): University of Iowa; 1981.
3.
LawtonMPBrodyEM. Assessment of older people: Self-maintaining and instrumental activities of daily living. Gerontologist1969;9:179–86.
4.
DienerEEmmonsRLargenJGriffinS.The Satisfaction with Life Scale. J Personal Assess1985;49:71–5.
5.
ReitanRMWolfsonD.Conventional intelligence measurements and neuropsychological concepts of adaptive abilities. J Clin Psychol1992;48:521.
6.
SchmidtM.Rey Auditory-Verbal Learning Test. Los Angeles (CA): Western Psychological Services; 1996.
7.
WechslerD.Wechsler Memory Scale-Third Edition. San Antonio (CA): Psychological Corporation; 1997.
8.
StryjerRStrousRDBarFWerberFShakedGBuhiriY, and others. Beneficial effect of donepezil augmentation for the management of comorbid schizophrenia and dementia. Clin Neuropharmacol2003;26:12–7.
9.
LenziAMaltintiEPoggiEFabrigioLColiE.Effects of rivastigmine on cognitive function and quality of life in patients with schizophrenia. Clin Neuropharmacol2003;26:317–21.
10.
TugalOYaziciK.A double-blind, placebo controlled, cross-over trial of adjunctive donepezil for cognitive impairment in schizophrenia. J Eur Coll Neuropsychopharmacol2003;13(Suppl 4):S294.